|
|
Article: Bioidentical hormones, estriol, and the FDA.(Shorts)(Food and Drug Administration)(Report)
- Article from:
- Townsend Letter
- Article date:
- April 1, 2009
- Author:
CopyrightCOPYRIGHT 2009 The Townsend Letter Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
The Women's Health Initiative study revealed in 2002 that hormone replacement pharmaceuticals, like Premarin (estrogen) and Prempro (estrogen and progestin), increase the risk of stroke and other serious problems. As a result, many women and their doctors turned to compounded bioidentical hormone replacement therapy (BHRT). These custom--made dugs, available only with a licensed practitioner's prescription, consist of individualized doses of hormones, including estriol, that are chemically identical to human hormones. Estriol is weak estrogen that gives some protection against breast and endometrial cancers. BHRT is believed to be safer than patented drugs, although no ...